Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04919525 · ClinicalTrials.gov registry record · NA

Remote Gamified Sensory Perceptual Training for Patients With Fibromyalgia: a Feasibility Trial

A NA study of Fibromyalgia, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
11
Enrollment target
1
Study location

NCT04919525 is a NA study of Fibromyalgia that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 11 participants, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04919525, a NA study of Fibromyalgia, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the feasibility of gamified sensory perceptual training in people with fibromyalgia. The primary aim is to determine the feasibility of at-home somatosensorial training for people with fibromyalgia. The researchers are determining the feasibility of using this device to decrease chronic neuropathic pain in people with fibromyalgia. The secondary aim is to survey participants' subjective report of clinical change after this program.

Conditions Studied

Interventions

  • DEVICE TrainPain

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2021-03-18
Est. Completion 2022-06-03
Phase NA

What the Registry Record Tells You About NCT04919525

The ClinicalTrials.gov registry entry for NCT04919525 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (94% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Fibromyalgia appearing as the primary indexed condition, and to 1 intervention - of which TrainPain is the first listed.

NCT04919525 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04919525 about?

NCT04919525 is a clinical study titled "Remote Gamified Sensory Perceptual Training for Patients With Fibromyalgia: a Feasibility Trial". The purpose of this study is to determine the feasibility of gamified sensory perceptual training in people with fibromyalgia. The primary aim is to determine the feasibility of at-home somatosensorial training for people with fibromyalgia. The researchers are determining the feasibility of using th...

What is the current status of trial NCT04919525?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2021-03-18. Estimated completion is 2022-06-03.

What conditions does trial NCT04919525 study?

This clinical trial studies the following conditions: Fibromyalgia.

What interventions are being tested in trial NCT04919525?

The interventions under investigation include: TrainPain (DEVICE).

Who is sponsoring clinical trial NCT04919525?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04919525 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fibromyalgia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.